Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05987917 · ClinicalTrials.gov registry record · NA
Clinical and Histological Evaluation of BTL-785F Non-invasive Treatment for Facial Rejuvenation
A NA study, sponsored by BTL Industries.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT05987917: Completed NA study, sponsored by BTL Industries.
NCT05987917 is a NA study that has completed, run by BTL Industries. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05987917, a NA study, has completed, sponsored by BTL Industries.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
This study will evaluate the clinical efficacy, safety and the performance of the BTL-785-2 applicator of the BTL-785F system for non-invasive treatment of facial wrinkles and correcting facial skin laxity.
Primary Outcome
Evaluation of the facial skin tissue to assess the changes related to levels of HA in the biopsies obtained from both treatment groups and control.
Interventions
- OTHER No Treatment
- DEVICE BTL-785-2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2021-01-25 |
| Est. Completion | 2022-01-03 |
| Phase | NA |
What the finished NCT05987917 record still lists
NCT05987917 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which No Treatment is the first listed.
NCT05987917 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05987917 about?
NCT05987917 is a clinical study titled "Clinical and Histological Evaluation of BTL-785F Non-invasive Treatment for Facial Rejuvenation". This study will evaluate the clinical efficacy, safety and the performance of the BTL-785-2 applicator of the BTL-785F system for non-invasive treatment of facial wrinkles and correcting facial skin laxity.
What is the current status of trial NCT05987917?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2021-01-25. Estimated completion is 2022-01-03.
What interventions are being tested in trial NCT05987917?
The interventions under investigation include: No Treatment (OTHER), BTL-785-2 (DEVICE).
Who is sponsoring clinical trial NCT05987917?
This trial is sponsored by BTL Industries, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05987917's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI